FDA product code · Ophthalmic
Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia
1 FDA decision since 2019. No recall names this code.
Intended to be worn on the surface of the eye in children who have myopia to: • Reduce the rate of progression of myopia, and • Optically correct myopic refractive error.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of QIT at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · QIT
9in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QIT
Too few QIT 510(k)s in any year since 2007 to give a median.
Recalls per year · QIT
No recall names QIT since 2007.
Adverse event reports per year · QIT
5in 2025
MAUDE reports naming product code QIT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 1 | — | 0 | 1 |
| 2020 | 4 | — | 0 | 0 |
| 2021 | 4 | — | 0 | 1 |
| 2022 | 4 | — | 0 | 3 |
| 2023 | 7 | — | 0 | 4 |
| 2024 | 5 | — | 0 | 2 |
| 2025 | 9 | — | 0 | 5 |
| 2026 | 1 | — | 0 | — |
Planning a device in QIT? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report